22,959views
of complete
of complete
2024
2023
2022
2021
multiple myeloma p. 436
multiple myeloma p. 436
multiple myeloma p. 436
multiple myeloma p. 436
multiple myeloma production of p. 436
multiple myeloma production of p. 436
multiple myeloma and p. 436
in multiple myeloma p. 436
amyloidosis p. 214
common metastases p. 202
ESR in p. 210
lab/diagnostic findings p. 728
metastatic calcification p. 213
osteoporosis p. 467
as plasma cell cancer p. 410
multiple myeloma vs p. 436
Multiple myeloma is a type of cancer that affects the plasma cells in the bone marrow. It is characterized by an overgrowth of abnormal plasma cells, which can cause damage to the bones, weaken the immune system, and produce an excess of certain proteins in the blood. Symptoms of multiple myeloma may include bone pain, fatigue, anemia, kidney problems, and frequent infections.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.